While a meta-analysis of six RCT concluding that metformin use in GDM is not significantly associated with adverse maternal or neonatal outcomes (Su and Wang, 2014), the evidence also fails to confirm a higher beneficial effect of metformin compared to the use of insulin. This evidence concerns the gene INS and gestational diabetes.